Concussion Protocols: What Providers Should Know to Diagnose, Treat, and Rehabilitate
Here are five things providers should know about concussions.
Democratizing Access: How Community Hospitals Can Drive the Next Wave of Robotic Bronchoscopy
As robotic systems grow more integrated, portable, and affordable, community hospitals will continue to play a leading role in redefining access to innovation.
How Artera is Using Agentic AI to Humanize Patient Care
Artera President Tom McIntyre talks about the practical application of AI in healthcare.
The FDA Is Fast-Tracking Health AI —Women’s Health Can’t Be Left Behind
Our biggest healthcare problems aren’t only cost or access, but the breakdown in how diagnoses are made, especially for women. Digital health’s new era of AI and real-time data is the most promising solution I’ve seen to fix this, but for these tools to work for women, they must be built on data that actually includes them.
Eyes on the Future: How Retinal Imaging Is Reframing Preventive Medicine
From cardiovascular disease to Alzheimer’s, the retina is proving to be the body’s most revealing health monitor, positioning optometrists at the forefront of early detection and integrated care.
presented by
Using Real World Data from the Patient Experience to Improve Drug Development
A new eBook published by MedCity News for PurpleLab highlights how RWD and SDOH can lead to more inclusive clinical trials and drugs that improve the quality of life for larger, diverse patient populations not only for NSCLC, but other conditions as well.
How AI Is Transforming Detection of Congenital Heart Defects
In prenatal cardiology, that clarity can mean earlier diagnoses, safer deliveries, and better supported families who are prepared for what lies ahead.
presented by
Survey on the Healthcare Financial Landscape Offers a Roadmap for Stakeholders
Zelis highlights how employers, payers, and consumers are integrating digital tools to manage healthcare costs.
Grail’s Galleri Blood Test Falls Short in Large Cancer-Screening Study, Shares Sink 50%
Despite missing statistical significance, Grail said the observation of trending improvement suggests potential for better results with more time, so the company is extending follow up by up to a year. More detailed trial results will be submitted for presentation at the annual meeting of the American Society of Clinical Oncology.
Danaher Drops $10B to Snatch Masimo in Diagnostics Push
Danaher is acquiring Masimo in a $10 billion deal aimed at expanding its diagnostics portfolio and deepening its presence in acute care settings. The move reflects a broader industry shift toward consolidation and integrated care, as large healthcare companies seek scale and more continuous clinical data inside hospitals.
Imaging Data Liquidity: The Foundation of Multimodal Medical Intelligence
Imaging has become a core input into how health systems understand disease, evaluate outcomes, plan capacity, and increasingly, how they learn.
From Pandemic Urgency to Practical Impact: How Diagnostics Investment Priorities Are Evolving
Speed still matters, but there’s been a shift in the industry. It’s not enough to be scientifically sound. Now, practicality is of utmost importance.
The New Blueprint: How Clever Care Health Plan is Scaling Its Member Experience [Video]
MedCity News was at the Vive conference and spoke with executives who shared their insights for the healthcare industry.
Could AI be the Antidote to ‘Sick Care’ in America?
Meeting people where they are with personalized AI-powered patient outreach could help traditional healthcare move beyond reactive medicine.
PGx Testing: Specialists Benefit From, and Build Upon Oncology’s Success
Some specialties, like oncology, have been quicker to embrace the promise of pharmacogenomics (PGx), and their successes can serve as a roadmap as others explore the impact it can have on quality, outcomes and patient satisfaction.
Can AI Bridge the Gaps in Women’s Healthcare? A Responsible Path Forward
We are only beginning to see how AI can impact women's health. As these technologies advance and become more integrated into healthcare workflows, we can expect more personalized care pathways that address women's needs across different life stages.
The 96-Hour Advantage: Why Early Diagnostic Accuracy Defines Clinical Outcomes
Effective specimen collection during the pivotal collection period guides everything that follows, from individual therapeutic decisions to large-scale community outbreak control.
Can Hospitals Use Blood Tests to Catch Cancer Earlier? Endeavor Health Is Trying to Find Out
Endeavor Health is studying Exact Sciences’ Cancerguard blood test to help see if multi-cancer detection should be deployed widely across hospitals. The five-year study aims to fill gaps in real-world evidence on how these tests perform and how they fit into routine healthcare.